Dr Chris Parker, (The Royal Marsden Hospital, London, UK) talks to ecancertv at ASCO GU 2015 about some of the most interesting and provocative research in genitourinary cancers emerging from the symposium.
Related Videos In Genitourinary Cancers
Thomas Powles, ASCO20: JAVELIN Bladder 100 Phase III Interim Analysis
It was a pleasure to speak to Thomas Powles about his plenery session on the phase III interim analysis of the JAVELIN Bladder 100 study on maintenance avelumab and best supportive care (BSC) versus BSC alone after platinum-based first-line chemotherapy in advanced urothelial carcinoma. Questions 1. What have we learned so far from clinical trials […]
Axel Merseburger, ASCO20: Clinical Updates in Urothelial Carcinoma and Renal Cell Carcinoma
We are joined by touchONCOLOGY European Oncology & Haematology Editor-in-Chief Dr Axel S Merseburger to discuss his highlights from the JAVELIN Bladder 100 Trial (Clinicaltrials.gov identifier: NCT02603432) and the KEYNOTE-426 phase III trial in patients with clear cell renal cell carcinoma (ClinicalTrials.gov identifier: NCT02853331). Questions 1. What are the current unmet needs in the treatment […]
Axel S Merseburger: OLUMPUS Trial, new non-surgical treatment for patients with low-grade UTUC
We are joined by our Editor-in-Chief for European Oncology & Haematology, Axel S Merseburger, to discuss the recent results of the OLYMPUS trial, an ongoing, single-arm, multicenter trial enrolling 71 patients with treatment-naïve or recurrent low-grade non-invasive UTUC with at least one measurable papillary tumor located above the ureteropelvic junction. For further information on this […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!